USFDA approves expanded MRI labelling for Abbott Proclaim DRG neurostimulation system for people suffering from chronic pain Ruchika Sharma23 Jan 2024 10:00 AM ISTAbbott Park, Ill.: Abbott has announced that the U.S. Food and Drug Administration (FDA) has approved expanded MRI labeling for its dorsal root...
Abbott receives USFDA nod for HPV screening solution Ruchika Sharma4 Nov 2023 3:39 PM ISTAbbott Park, Ill.: Abbott has received U.S. Food and Drug Administration (FDA) approval for its molecular human papillomavirus or HPV screening...
Indian pharmaceutical market registers 9 percent growth in September: IQVIA Report Susmita Roy3 Nov 2023 5:43 PM ISTNew Delhi: The Indian Pharmaceutical Market (IPM) has witnessed a spike of nine percent in September 2023, according to International Quality and...
Abbott Gets CDSCO Panel Nod to Study Dydrogesterone Modified Release Tablets Dr. Divya Colin10 Oct 2023 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization (CDSCO) has given its nod to drug major...
Abbott broadens access to cutting edge biosimilars in key emerging markets Ruchika Sharma24 Sept 2023 12:30 PM ISTAbbott Park, Ill.: Abbott has announced an agreement with Spain-based mAbxience Holdings S.L. to commercialize several biosimilars focusing on...
Bigfoot becomes wholly owned subsidiary of Abbott Ruchika Sharma23 Sept 2023 10:00 AM ISTAbbott Park, Ill.: Abbott has announced it has completed the acquisition of Bigfoot Biomedical, a company developing smart insulin management...
Abbott voluntarily stopped Digene production at Goa facility, implementing corrective actions Ruchika Sharma15 Sept 2023 1:58 PM ISTHyderabad: Drug maker Abbott on Thursday said it is implementing corrective actions at its Goa-based facility from where it had produced antacid...
52 percent Indian families have had 1 member face unknown side effects from medicine: Report MD Bureau8 Sept 2023 1:45 PM ISTNew Delhi: A whopping 52 per cent Indian families have had at least one member face unknown side effects from medicine, according to a report on...
Popular antacid Digene gel receives warning alert from DCGI, Abbott initiates recall Roshni Dhar8 Sept 2023 10:34 AM ISTThe popular antacid Digene gel has received a warning alert from the Drugs Control General of India (DCGI) following which batches of the product have...
Health Bulletin 07/September/2023 Roshni Dhar7 Sept 2023 5:41 PM ISTHere are the top health stories for the day:DCGI flags popular antacid Digene Gel, Abbott initiates recallThe popular antacid Digene gel has received...
DCGI flags popular antacid Digene Gel, Abbott initiates recall Farhat Nasim6 Sept 2023 7:25 PM ISTNew Delhi: The popular antacid Digene gel has received a warning alert from the Drugs Control General of India (DCGI) following which batches of the...
Abbott to buy insulin management company Bigfoot Biomedical Ruchika Sharma6 Sept 2023 11:30 AM ISTAbbott Park, III: Abbott and Bigfoot Biomedical have announced a definitive agreement for Abbott to acquire Bigfoot, a company developing...
